⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7196388 | 0.85 | TDP1 (0.41) | — | |
| SCHEMBL11639063 | 0.81 | LMNA (0.35) | — | |
| SCHEMBL11527420 | 0.78 | — | — | |
| Chloroform SCHEMBL28140383 | 0.78 | TDP1 (0.71) | — | |
| SCHEMBL3196745 | 0.76 | — | — | |
| SCHEMBL5902723 | 0.75 | TDP1 (0.56) | — | |
| SCHEMBL17113787 | 0.73 | — | — | |
| SCHEMBL12258200 | 0.73 | TDP1 (0.53) | — | |
| SCHEMBL103502 | 0.73 | — | — | |
| Hypochlorous Acid SCHEMBL6139372 | 0.72 | TDP1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3668882-A1 | PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | Cancer Research Technology Limited (GB) | 2020-06-24 | — | — | EP | disclosed |
| WO-2019034890-A1 | PYRROLO[2,3-B]PYRIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2019-02-21 | — | — | WO | disclosed |
| EP-2834234-A1 | FUSED CYCLOPENTYL ANTAGONISTS OF CCR2 | Janssen Pharmaceutica, N.V. (BE) | 2015-02-11 | — | — | EP | disclosed |
| WO-2013152269-A1 | FUSED CYCLOPENTYL ANTAGONISTS OF CCR2 | JANSSEN PHARMACEUTICA NV (BE) | 2013-10-10 | — | — | WO | disclosed |
| US-7834176-B2 | Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E | SANDOZ AG (CH) | 2010-11-16 | — | — | US | disclosed |
| EP-1198456-B1 | POTASSIUM CHANNEL OPENERS | ABBOTT LAB (US) | 2007-09-19 | — | — | EP | disclosed |
| WO-2007087555-A2 | NOVEL POLYMORPH 'FORM E ' OF OLANZAPINE (2-METHYL-4- (4-METHYL-1-PIPERAZINYL) -10H-THIENO [2, 3-B] [1, 5] BENZODIAZEPINE) AND PREPARATION OF THE ANHYDROUS NON-SOLVATED CRYSTALLINE POLYMORPHIC 'FORM I' OF OLANZAPINE FROM THE POLYMORPHIC OLANZAPINE 'FORM E' | SANDOZ AG (CH) | 2007-08-02 | — | — | WO | disclosed |
| US-20070173496-A1 | Novel polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E | SANDOZ AG (CH) | 2007-07-26 | — | — | US | disclosed |
| US-6645968-B2 | E.g., N-(1-((anilinocarbonyl)amino)-2,2,2-trichloroethyl)-4-methyl-benzamide; antiepileptic, -ischemic and cardiotonic agents; sexual, eating and urogenital disorders; asthma; migraines; | ABBOTT LABORATORIES | 2003-11-11 | — | — | US | disclosed |
| WO-2002038614-A9 | CROSSLINKED POLYSACCHARIDE, OBTAINED BY CROSSLINKING WITH SUBSTITUTED POLYETHYLENE GLYCOL, AS SUPERABSORBENT | GROUPE LYSAC INC LYSAC GROUP I (CA) | 2003-01-23 | — | — | WO | disclosed |
| US-6495576-B2 | N-(1-((3,4-DIOXO-2-(3-PYRIDINYLAMINO)-1-CYCLOBUTEN-1-YL)AMINO) -2,2-DIMETHYLPROPYL)-4-METHYLBENZAMIDE FOR EXAMPLE; TREATING BLADDER OVERACTIVITY, BENIGN PROSTATIC HYPERPLASIA, PREMATURE LABOR, AND SEXUAL DISORDERS | ABBOTT LABORATORIES | 2002-12-17 | — | — | US | disclosed |
| US-20020165264-A1 | Aminal diones as potassium channel openers | ABBOTT LABORATORIES | 2002-11-07 | — | — | US | disclosed |
| US-20020147230-A1 | Aminal Diones as potassium channel openers | ABBOTT LABORATORIES | 2002-10-10 | — | — | US | disclosed |
| WO-2002038614-A1 | CROSSLINKED POLYSACCHARIDE, OBTAINED BY CROSSLINKING WITH SUBSTITUTED POLYETHYLENE GLYCOL, AS SUPERABSORBENT | GROUPE LYSAC INC./LYSAC GROUP INC. (CA) | 2002-05-16 | — | — | WO | disclosed |
| US-20020028836-A1 | Potassium channel openers | ABBVIE INC. | 2002-03-07 | — | — | US | disclosed |
| US-5874600-A | HYDROGENATION OF AN ALKYL 3-OXO-2-ALKYLCYCLOPENTANEACETIC ACID USING A CATALYST OF A RUTHENIUM COMPLEX REACTED WITH A BIDENTATE DIPHOSPHINE LIGAND AND A NONCOORDINATING ACID; STEREOSPECIFIC; PERFUMES; HEDRONE? | FIRMENICH SA (CH) | 1999-02-23 | — | — | US | disclosed |